Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

narmac

Rank: Vice President [?]

Points: 3973 [?]

Votes: 36 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics

posted on Nov 30, 2016 04:09PM

November 30th.

https://ceo.ca/@nasdaq/viracta-acquires-phase-2-epigenetic-drug-candidate

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply